Table 1.
Demographic, clinical, and pathological characteristics of Alaska Native (AN) gastric cancer molecular expression subgroup (n = 85) and next-generation sequencing (NGS) subgroup (n = 82).
| Characteristics | Molecular Expression n (%) | NGS n (%) |
|---|---|---|
| Age | ||
| Median (range) | 60.9 (21–90) | 61.2 (21–90) |
| Gender | ||
| Male | 52 (61.2) | 51 (62.2) |
| Female | 33 (38.8) | 31 (37.8) |
| Stage at diagnosis | ||
| I | 23 (27.1) | 18 (22.0) |
| II | 16 (18.8) | 17 (20.7) |
| III | 12 (14.1) | 11 (13.4) |
| IV | 34 (40.0) | 36 (43.9) |
| Anatomic site | ||
| GE JX | 13 (15.3) | 14 (17.1) |
| Fundus | 7 (8.2) | 6 (7.3) |
| Body a | 21 (24.7) | 20 (24.4) |
| Antrum | 10 (11.8) | 10 (12.2) |
| Pylorus | 14 (16.5) | 14 (17.1) |
| Overlapping | 20 (23.5) | 18 (22.0) |
| Lauren histological type | ||
| Intestinal | 41 (48.2) | 41 (50.0) |
| Diffuse | 44 (51.8) | 41 (50.0) |
| Grade | ||
| G2 | 25 (29.4) | 25 (30.5) |
| G3 | 60 (70.6) | 57 (69.5 |
| Signet-ring cell presence | ||
| No | 60 (70.6) | 60 (73.2) |
| Yes | 25 (29.4) | 22 (26.8) |
a Body includes lesser and greater curvature. Abbreviation: GE JX, gastroesophageal junction.